← Browse by Condition
Medical Condition

disorder of consciousness

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for disorder of consciousness sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — disorder of consciousness Clinical Trials

How many clinical trials are currently recruiting for disorder of consciousness?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for disorder of consciousness, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for disorder of consciousness?
disorder of consciousness research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a disorder of consciousness clinical trial?
Eligibility criteria for disorder of consciousness trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Konkuk University Medical Center 1 trial
University Hospital, Toulouse 1 trial
Huashan Hospital 1 trial
Anna Estraneo 1 trial

Recruiting Clinical Trials

NCT04427241 Phase 4
Recruiting
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Enrollment
12 pts
Location
South Korea
Sponsor
Konkuk University Medical Cent...
View Trial →
NCT06617377
Recruiting
Combined Whole-brain Structural and Functional MRI for the Prediction of Neurological Recovery After Cardiac Arrest
Enrollment
263 pts
Location
France
Sponsor
University Hospital, Toulouse
View Trial →
NCT06896279
Recruiting
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders
Enrollment
20 pts
Location
China
Sponsor
Huashan Hospital
View Trial →
NCT06469983
Recruiting
Robotic vs. Traditional Verticalization in Patients With Severe Acquired Brain Injury: a Randomized Controlled Trial
Enrollment
118 pts
Location
Italy
Sponsor
Anna Estraneo
View Trial →

Related Conditions

hemorrhagic stroke (1) coma (1) cardiac arrest (1) neurologic disorder (1) temporal interference stimulation (1) acquired brain injury (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology